Global Ventricular Assist Devices Market Trends, Forecast Report 2025-2037
Ventricular Assist Devices Market size is set to grow from USD 2.77 billion to USD 8.96 billion, registering a CAGR of around 9.4% during the forecast timeline, between 2025 and 2037. In the year 2025, the industry size of ventricular assist devices is estimated at USD 2.98 billion.
The market growth can be ascribed to growing prevalence of cardiovascular diseases, rapid globalization, and the increasing adoption of unhealthy lifestyles in developing countries. Based on the data provided by the World Health Organization (WHO), cardiovascular diseases were stated to be accounting for nearly 17.9 death in 2019 across the globe.
Additionally, mounting prevalence of congenital heart disease and ongoing technological advancement in medical equipment along with a significant increment in global healthcare expenditure are projected to influence the market growth. It has been observed that congenital heart disease (CHDs) affects approximately 38,000 births every year solely in the USA. Moreover, ventricular assist devices (VAD) are mechanical circulatory support devices that provide assistance to pump blood from the lower chamber of the heart to the rest of the body. The demand for these devices is up surged by the rising awareness of the early diagnosis of heart diseases.
Ventricular Assist Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Cases of Heart Attacks to Boost the Market Growth- For instance, approximately 0.08 million die every year in the United States alone.A heart attack or a myocardial infarction is a condition when the blood flow gets disrupted in a certain heart muscle. Such blockage of blood results in severe damage to the heart that can cause death or the lifetime functionality of the heart. Since ventricular assist devices are helpful to pump blood conveniently to the body, cardiologists prefer them more often. Hence, such a requirement is projected to propel the growth of the market over the forecast period.
- Rising Penetration of Stroke Owing to Increasing Obesity Issues- It is observed that in every 5 adults, 1 of them dies on account of a stroke under the age of 25.
- Increasing Prevalence of Coronary Artery Disease with Growing Changes in Food Habits- As of 2020, coronary heart disease was projected to account for approximately 0.35 million deaths across the globe.
- Significant Utilization in the Treatment of Cardiac Arrhythmia Owing to Rising Disposable Income- In 2021, cardiac arrhythmia was estimated to be affecting between 5-12 million individuals globally.
- Long Waiting Periods Associated with Heart Surgeries or Transplants - As per the Health Resources and Administration of the U.S. in 2018, 3980 candidates were included on the waiting list for heart surgeries.
Challenges
- High Cost Associated with Requisite Equipment The equipment used is very expensive which a small clinic cannot afford. The high cost of maintenance and increasing hospitalization cost for these devices is more than any conventional therapy. The implantation of these devices is also costly that is estimated to limit the adoption and eventually hamper the market growth.
- Lack of Skilled Medical Professionals
- Disrupted Supply-Chain due to COVID-19
Ventricular Assist Devices Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
9.4% |
|
Base Year Market Size (2024) |
USD 2.77 billion |
|
Forecast Year Market Size (2037) |
USD 8.96 billion |
|
Regional Scope |
|
Ventricular Assist Devices Segmentation
End-user (Specialty Clinics, Hospitals, ASCs)
The hospitals segment is projected to witness noteworthy growth in the ventricular assist devices market till 2037, led by mounting patient pool in hospitals over the recent decades, the increasing number of hospitalization days, and the growing number of physicians in developing and low-income countries. As of 2018, it was observed that approximately 100 million people visited the emergency department.
Our in-depth analysis of the global market includes the following segments:
|
By Product Type |
|
|
By Design |
|
|
By Application |
|
|
By End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportVentricular Assist Devices Industry - Regional Synopsis
The North America region ventricular assist devices market is estimated to account for largest revenue share by 2037. The market growth is impelled by increasing cases of cardiac arrests in the region, rising adoption of new technological devices, and growing agreements for collaborations and development by the key players. Cardiac arrest is one of the leading causes of death. For instance, the annual rate of the occurrence of out-of-hospital cardiac arrests in the United States is poised to be nearly 0.03 million, while every 40 seconds, one person dies on account of a heart attack in the same region.
Companies Dominating the Ventricular Assist Devices Landscape
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sun Medical Technology Research Corpï¼Å½
- Berlin Heart GmbH
- Abiomed, Inc.
- ReliantHeart, Inc.
- Jarvik Heart, Inc
- LivaNova, Inc.
- Boston Scientific Corporation
- Calon cardio-Technology Ltd.
- Medtronic plc
In the News
-
Abiomed, Inc. to unload with Impella CP for 30 minutes before percutaneous coronary intervention. Impella CP is associated with the patients having decreased Infarct size.
-
Abbott Laboratories to unveil its Amplatzer “Talisman”, a PFO Occlusion System. The system is developed to close the holes in the heart preventing the risk of heart stroke. The system is very beneficial for people living with patent foramen ovale (PFO).
Author Credits: Radhika Pawar
- Report ID: 1410
- Published Date: Jan 17, 2025
- Report Format: PDF, PPT
